CYTOPHAGE TECHNOLOGIES LTD (CYTO.CA) Stock Income Statement
Canada • TSX Venture Exchange • TSX-V:CYTO • CA2328211081
0.16 CAD
+0.01 (+3.23%)
Last: Feb 2, 2026, 07:00 PM
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 4.48M | 5.17M | 5.04M | 3.66M | 3.20M | |||
| Research and Development | 134.50K | 22.90K | 441.90K | 442.60K | 424.80K | |||
| Selling, General, and Administrative Expenses | 3.64M | 4.44M | 4.08M | 3.44M | 2.94M | |||
| Operating Income | -4.48M | -5.17M | -5.04M | -3.66M | -3.20M | |||
| Interest Income/Expense | -75.30K | 40.00K | -30.50K | -20.10K | -30.50K | |||
| Other Income/Expense | 53.70K | 31.40K | 445.10K | N/A | N/A | |||
| Non Recurring Items | -67.10K | -2.76M | -10.90K | N/A | N/A | |||
| Income Before Taxes | -4.57M | -7.86M | -4.64M | -3.68M | -3.24M | |||
| Net Income | -4.57M | -7.86M | -4.64M | -3.68M | -3.24M | |||
| EBITDA | -3.78M | -4.47M | -4.53M | -3.30M | -2.91M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.08 | -0.15 | -0.55 | -0.44 | -0.38 | |||
| Statistics | ||||||||
All data in CAD